Top Story

Medical Affairs
Implications for Medical Affairs Teams in 2024 and Beyond
April 25th, 2024
In 2024, medical affairs teams are pivotal in driving strategic impact within the pharmaceutical industry. They navigate challenges in organizational transformation, artificial intelligence (AI) integration, and omnichannel engagement. Transforming organizational structures involves alignment with broader goals and excelling in scientific engagement. AI offers potential to streamline [...]
Read More

Latest Stories

Market Access
Expansion and Enhancement of Telehealth and Teletherapy Services Post-Pandemic
April 17th, 2024
Read More
Integrated Evidence Assessment & Planning
Biden Administration Launches Global Health Security Strategy to Combat Infectious Diseases
April 16th, 2024
Read More
Real World Evidence
Study Reveals Racial Disparities in Prostate Cancer Care
April 16th, 2024
Read More
Healthcare Financing
Regeneron Launches $500M Venture Investment Arm
April 15th, 2024
Read More
Health Policy
FDA Proposes Eliminating Biosimilars’ Interchangeability Designation
April 15th, 2024
Read More
Health Policy
House Committee Grills FDA Commissioner on Drug Shortages and Inspections
April 12th, 2024
Read More

HEOR

ISPOR 2024: Keynote Speakers and Sessions Announced

Jasmin Skinner2024-04-23T14:43:21-04:00April 23rd, 2024|

Forecast of the Global Real World Evidence (RWE) Solutions Market

Jasmin Skinner2024-04-22T13:54:24-04:00April 22nd, 2024|

Bristol Myers Squibb Expands Partnership with Cellares in $380 Million Deal

Paige McGarry2024-04-22T13:23:47-04:00April 22nd, 2024|

RWE

GSK Advances Oligonucleotide Research with Elsie Biotechnologies Platform License

Paige McGarry2024-04-01T13:24:27-04:00February 14th, 2024|

Can We Trust the Data? The Case for Validation

Hayleigh Culliton2024-04-01T13:28:16-04:00January 23rd, 2024|

Trinity Life Sciences Reports Promising Opportunities in China’s 2022 NRDL for Innovative Drugs

Paige McGarry2024-04-01T13:24:28-04:00December 20th, 2023|

Market Access

Metagenomi Announces IPO Amid Biotech Sector’s Cooling Investor Interest

Paige McGarry2024-04-01T13:28:16-04:00January 5th, 2024|

FDA Approves Groundbreaking CRISPR Gene-Editing Medicine for Sickle Cell Disease

Paige McGarry2024-04-01T13:28:17-04:00December 8th, 2023|

Global Angiography Catheter Market: Surge in Demand Driven by Minimally Invasive Procedures and Cardiovascular Disease Prevalence

Paige McGarry2024-04-01T13:28:17-04:00December 7th, 2023|

Featured Webinars

Practical AI: Adding Insight to the Patient Journey with Digital Phenotyping

Thursday, May 23, 2024

Sponsor: OM1

In this webinar, Dr. Joseph Zabinski will discuss the digital phenotyping process and several concrete applications to demonstrate how AI can [...]

Insights from the 2024 Salary Survey Report by HealthEconomics.com

Wednesday, May 1, 2024

Webinar Host: Scientist.com

The live session will focus on the latest salary and bonus trends for professionals in the field, including a comprehensive overview [...]

Beyond Accelerated Approvals: External Control Arms

Wednesday, April 10, 2024

Sponsor: Cardinal Health

Hear this panel's discussion on the strategic use of external control arms and, if done correctly, how they can help bring [...]

Delphi Panels: What Are They Good For?

Tuesday, March 12, 2024

Sponsor: Partnership for Health Analytic Research (PHAR)

In this webinar, experts deep dive into Delphi panel methods, their implementation, and pharmaceutical industry insights on the panels' use and [...]

Handpicked Promotions & Highlights

Latest in Catalyst News powered by BioPharmCatalyst

04/26/2024 04:44 PM ET

ImmunityBio ABIO earnings announcement

ARCA biopharma revealed their most recent quarterly earnings data for Q1. EPS was reported to be -$0.14.

The market liked what it heard. ARCA biopharma rocketed up $0.10 (+2.87%) to $3.58 on light volume [...]

04/26/2024 04:44 PM ET

ProKidney PTCT earnings announcement

PTC Therapeutics exceeded their revenue estimate and fell in line with their EPS estimate, according to their recent quarterly earnings data. Revenue was $210.12M, exceeding estimates by 23.8%.

Not surprisingly, the [...]

04/25/2024 04:46 PM ET

Processa Pharmaceuticals BCDA date announcement

BioCardia has an announcement scheduled for December 31, 2024 regarding their recent Phase 3 trial of CardiAMP (BCDA-02). The community is currently bullish on the prospects of progression, as the bulls outnumber bears by five [...]